NYSE:NVOPharmaceuticals
Assessing Novo Nordisk (NYSE:NVO) Valuation After Recent Share Price Volatility
Recent performance snapshot
Novo Nordisk (NYSE:NVO) has drawn attention after a mixed run in the stock, with a gain of about 15% over the past month but a decline of roughly 5% over the past 3 months.
See our latest analysis for Novo Nordisk.
Stepping back from the recent rebound, Novo Nordisk’s 14.8% 1 month share price return contrasts with a weaker year to date move and a 1 year total shareholder return that has declined 31%. This hints at improving short term momentum after a tougher...